nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—ABCB1—colon cancer	0.454	1	CbGaD
Eletriptan—CYP2A6—Fluorouracil—colon cancer	0.0856	0.317	CbGbCtD
Eletriptan—CYP2C9—Capecitabine—colon cancer	0.0497	0.184	CbGbCtD
Eletriptan—ABCB1—Irinotecan—colon cancer	0.0298	0.11	CbGbCtD
Eletriptan—CYP2C9—Fluorouracil—colon cancer	0.0294	0.109	CbGbCtD
Eletriptan—ABCB1—Vincristine—colon cancer	0.026	0.0965	CbGbCtD
Eletriptan—CYP3A4—Irinotecan—colon cancer	0.0178	0.0661	CbGbCtD
Eletriptan—ABCB1—Methotrexate—colon cancer	0.0158	0.0584	CbGbCtD
Eletriptan—CYP3A4—Vincristine—colon cancer	0.0156	0.0578	CbGbCtD
Eletriptan—HTR7—myenteric nerve plexus—colon cancer	0.0115	0.193	CbGeAlD
Eletriptan—HTR7—vein—colon cancer	0.00738	0.125	CbGeAlD
Eletriptan—HTR1B—blood vessel—colon cancer	0.00304	0.0513	CbGeAlD
Eletriptan—HTR1D—blood vessel—colon cancer	0.00294	0.0497	CbGeAlD
Eletriptan—HTR7—endothelium—colon cancer	0.00254	0.0429	CbGeAlD
Eletriptan—HTR7—blood vessel—colon cancer	0.00234	0.0396	CbGeAlD
Eletriptan—PTGS1—endothelium—colon cancer	0.00176	0.0296	CbGeAlD
Eletriptan—PTGS1—blood vessel—colon cancer	0.00162	0.0273	CbGeAlD
Eletriptan—HTR2B—smooth muscle tissue—colon cancer	0.00128	0.0217	CbGeAlD
Eletriptan—CYP2A6—vagina—colon cancer	0.00116	0.0196	CbGeAlD
Eletriptan—HTR7—epithelium—colon cancer	0.00114	0.0193	CbGeAlD
Eletriptan—HTR1A—renal system—colon cancer	0.00111	0.0187	CbGeAlD
Eletriptan—HTR7—smooth muscle tissue—colon cancer	0.0011	0.0186	CbGeAlD
Eletriptan—HTR7—renal system—colon cancer	0.00106	0.0179	CbGeAlD
Eletriptan—HTR2B—digestive system—colon cancer	0.00101	0.0171	CbGeAlD
Eletriptan—CYP2A6—liver—colon cancer	0.000981	0.0166	CbGeAlD
Eletriptan—ABCB1—blood vessel—colon cancer	0.000957	0.0162	CbGeAlD
Eletriptan—HTR2B—vagina—colon cancer	0.000895	0.0151	CbGeAlD
Eletriptan—HTR7—digestive system—colon cancer	0.000868	0.0146	CbGeAlD
Eletriptan—CYP2C19—digestive system—colon cancer	0.000847	0.0143	CbGeAlD
Eletriptan—PTGS1—epithelium—colon cancer	0.000788	0.0133	CbGeAlD
Eletriptan—PTGS1—smooth muscle tissue—colon cancer	0.000759	0.0128	CbGeAlD
Eletriptan—CYP2C19—vagina—colon cancer	0.000748	0.0126	CbGeAlD
Eletriptan—PTGS1—renal system—colon cancer	0.000731	0.0123	CbGeAlD
Eletriptan—CYP2C9—digestive system—colon cancer	0.000657	0.0111	CbGeAlD
Eletriptan—HTR7—liver—colon cancer	0.000646	0.0109	CbGeAlD
Eletriptan—CYP2C19—liver—colon cancer	0.000631	0.0107	CbGeAlD
Eletriptan—CYP3A4—renal system—colon cancer	0.000611	0.0103	CbGeAlD
Eletriptan—CYP2D6—renal system—colon cancer	0.000601	0.0101	CbGeAlD
Eletriptan—PTGS1—digestive system—colon cancer	0.0006	0.0101	CbGeAlD
Eletriptan—HTR2B—lymph node—colon cancer	0.000579	0.00977	CbGeAlD
Eletriptan—ABCB1—embryo—colon cancer	0.000571	0.00964	CbGeAlD
Eletriptan—PTGS1—vagina—colon cancer	0.00053	0.00894	CbGeAlD
Eletriptan—CYP3A4—digestive system—colon cancer	0.000501	0.00846	CbGeAlD
Eletriptan—CYP2D6—digestive system—colon cancer	0.000493	0.00832	CbGeAlD
Eletriptan—CYP2C9—liver—colon cancer	0.000489	0.00826	CbGeAlD
Eletriptan—ABCB1—epithelium—colon cancer	0.000466	0.00787	CbGeAlD
Eletriptan—ABCB1—renal system—colon cancer	0.000432	0.0073	CbGeAlD
Eletriptan—Agitation—Vincristine—colon cancer	0.000416	0.00192	CcSEcCtD
Eletriptan—Polyuria—Methotrexate—colon cancer	0.000416	0.00191	CcSEcCtD
Eletriptan—Angina pectoris—Capecitabine—colon cancer	0.000413	0.0019	CcSEcCtD
Eletriptan—Ill-defined disorder—Irinotecan—colon cancer	0.000409	0.00188	CcSEcCtD
Eletriptan—Anaemia—Irinotecan—colon cancer	0.000408	0.00188	CcSEcCtD
Eletriptan—Bronchitis—Capecitabine—colon cancer	0.000407	0.00188	CcSEcCtD
Eletriptan—Vertigo—Vincristine—colon cancer	0.000407	0.00187	CcSEcCtD
Eletriptan—Abdominal discomfort—Capecitabine—colon cancer	0.000406	0.00187	CcSEcCtD
Eletriptan—Leukopenia—Vincristine—colon cancer	0.000405	0.00187	CcSEcCtD
Eletriptan—Malaise—Irinotecan—colon cancer	0.000398	0.00183	CcSEcCtD
Eletriptan—Vertigo—Irinotecan—colon cancer	0.000396	0.00182	CcSEcCtD
Eletriptan—Syncope—Irinotecan—colon cancer	0.000396	0.00182	CcSEcCtD
Eletriptan—Leukopenia—Irinotecan—colon cancer	0.000395	0.00182	CcSEcCtD
Eletriptan—Convulsion—Vincristine—colon cancer	0.000392	0.00181	CcSEcCtD
Eletriptan—Hypertension—Vincristine—colon cancer	0.000391	0.0018	CcSEcCtD
Eletriptan—Anaemia—Fluorouracil—colon cancer	0.00039	0.0018	CcSEcCtD
Eletriptan—Loss of consciousness—Irinotecan—colon cancer	0.000388	0.00178	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Methotrexate—colon cancer	0.000387	0.00178	CcSEcCtD
Eletriptan—Myalgia—Vincristine—colon cancer	0.000386	0.00178	CcSEcCtD
Eletriptan—Weight increased—Capecitabine—colon cancer	0.000386	0.00178	CcSEcCtD
Eletriptan—Cough—Irinotecan—colon cancer	0.000385	0.00177	CcSEcCtD
Eletriptan—Weight decreased—Capecitabine—colon cancer	0.000383	0.00176	CcSEcCtD
Eletriptan—Hyperglycaemia—Capecitabine—colon cancer	0.000382	0.00176	CcSEcCtD
Eletriptan—Hypertension—Irinotecan—colon cancer	0.000381	0.00175	CcSEcCtD
Eletriptan—Leukopenia—Fluorouracil—colon cancer	0.000378	0.00174	CcSEcCtD
Eletriptan—CYP3A4—liver—colon cancer	0.000373	0.0063	CbGeAlD
Eletriptan—Acute coronary syndrome—Capecitabine—colon cancer	0.000372	0.00171	CcSEcCtD
Eletriptan—Discomfort—Irinotecan—colon cancer	0.000371	0.00171	CcSEcCtD
Eletriptan—Neuropathy peripheral—Capecitabine—colon cancer	0.00037	0.0017	CcSEcCtD
Eletriptan—Myocardial infarction—Capecitabine—colon cancer	0.00037	0.0017	CcSEcCtD
Eletriptan—Oedema—Vincristine—colon cancer	0.00037	0.0017	CcSEcCtD
Eletriptan—Stomatitis—Capecitabine—colon cancer	0.000368	0.0017	CcSEcCtD
Eletriptan—Conjunctivitis—Capecitabine—colon cancer	0.000367	0.00169	CcSEcCtD
Eletriptan—CYP2D6—liver—colon cancer	0.000367	0.0062	CbGeAlD
Eletriptan—Convulsion—Fluorouracil—colon cancer	0.000366	0.00169	CcSEcCtD
Eletriptan—Osteoarthritis—Methotrexate—colon cancer	0.000365	0.00168	CcSEcCtD
Eletriptan—Confusional state—Irinotecan—colon cancer	0.000363	0.00167	CcSEcCtD
Eletriptan—Nervous system disorder—Vincristine—colon cancer	0.000363	0.00167	CcSEcCtD
Eletriptan—Oedema—Irinotecan—colon cancer	0.00036	0.00166	CcSEcCtD
Eletriptan—Myalgia—Fluorouracil—colon cancer	0.00036	0.00166	CcSEcCtD
Eletriptan—ABCB1—lymphoid tissue—colon cancer	0.000359	0.00606	CbGeAlD
Eletriptan—Hyperhidrosis—Vincristine—colon cancer	0.000357	0.00165	CcSEcCtD
Eletriptan—Epistaxis—Capecitabine—colon cancer	0.000356	0.00164	CcSEcCtD
Eletriptan—Discomfort—Fluorouracil—colon cancer	0.000355	0.00164	CcSEcCtD
Eletriptan—ABCB1—digestive system—colon cancer	0.000355	0.00599	CbGeAlD
Eletriptan—Shock—Irinotecan—colon cancer	0.000354	0.00163	CcSEcCtD
Eletriptan—Nervous system disorder—Irinotecan—colon cancer	0.000353	0.00163	CcSEcCtD
Eletriptan—Anorexia—Vincristine—colon cancer	0.000352	0.00162	CcSEcCtD
Eletriptan—Hyperhidrosis—Irinotecan—colon cancer	0.000348	0.0016	CcSEcCtD
Eletriptan—Confusional state—Fluorouracil—colon cancer	0.000348	0.0016	CcSEcCtD
Eletriptan—Mood swings—Methotrexate—colon cancer	0.000346	0.00159	CcSEcCtD
Eletriptan—Hypotension—Vincristine—colon cancer	0.000345	0.00159	CcSEcCtD
Eletriptan—Bradycardia—Capecitabine—colon cancer	0.000345	0.00159	CcSEcCtD
Eletriptan—Oedema—Fluorouracil—colon cancer	0.000345	0.00159	CcSEcCtD
Eletriptan—Anorexia—Irinotecan—colon cancer	0.000343	0.00158	CcSEcCtD
Eletriptan—Ataxia—Methotrexate—colon cancer	0.000343	0.00158	CcSEcCtD
Eletriptan—PTGS1—lymph node—colon cancer	0.000343	0.00578	CbGeAlD
Eletriptan—Rhinitis—Capecitabine—colon cancer	0.00034	0.00157	CcSEcCtD
Eletriptan—Nervous system disorder—Fluorouracil—colon cancer	0.000338	0.00156	CcSEcCtD
Eletriptan—Hypoaesthesia—Capecitabine—colon cancer	0.000337	0.00155	CcSEcCtD
Eletriptan—Liver function test abnormal—Methotrexate—colon cancer	0.000337	0.00155	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Vincristine—colon cancer	0.000337	0.00155	CcSEcCtD
Eletriptan—Pharyngitis—Capecitabine—colon cancer	0.000337	0.00155	CcSEcCtD
Eletriptan—Tachycardia—Fluorouracil—colon cancer	0.000337	0.00155	CcSEcCtD
Eletriptan—Hypotension—Irinotecan—colon cancer	0.000336	0.00155	CcSEcCtD
Eletriptan—Urinary tract disorder—Capecitabine—colon cancer	0.000335	0.00154	CcSEcCtD
Eletriptan—Insomnia—Vincristine—colon cancer	0.000334	0.00154	CcSEcCtD
Eletriptan—Oedema peripheral—Capecitabine—colon cancer	0.000334	0.00154	CcSEcCtD
Eletriptan—Urethral disorder—Capecitabine—colon cancer	0.000332	0.00153	CcSEcCtD
Eletriptan—Paraesthesia—Vincristine—colon cancer	0.000332	0.00153	CcSEcCtD
Eletriptan—Anorexia—Fluorouracil—colon cancer	0.000329	0.00151	CcSEcCtD
Eletriptan—ABCB1—bone marrow—colon cancer	0.000327	0.00552	CbGeAlD
Eletriptan—Visual impairment—Capecitabine—colon cancer	0.000327	0.0015	CcSEcCtD
Eletriptan—Insomnia—Irinotecan—colon cancer	0.000326	0.0015	CcSEcCtD
Eletriptan—Paraesthesia—Irinotecan—colon cancer	0.000323	0.00149	CcSEcCtD
Eletriptan—Hypotension—Fluorouracil—colon cancer	0.000322	0.00148	CcSEcCtD
Eletriptan—Decreased appetite—Vincristine—colon cancer	0.000321	0.00148	CcSEcCtD
Eletriptan—Dyspnoea—Irinotecan—colon cancer	0.000321	0.00148	CcSEcCtD
Eletriptan—Somnolence—Irinotecan—colon cancer	0.00032	0.00147	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Vincristine—colon cancer	0.000319	0.00147	CcSEcCtD
Eletriptan—Fatigue—Vincristine—colon cancer	0.000319	0.00147	CcSEcCtD
Eletriptan—Dyspepsia—Irinotecan—colon cancer	0.000317	0.00146	CcSEcCtD
Eletriptan—Tinnitus—Capecitabine—colon cancer	0.000316	0.00146	CcSEcCtD
Eletriptan—Pain—Vincristine—colon cancer	0.000316	0.00146	CcSEcCtD
Eletriptan—Constipation—Vincristine—colon cancer	0.000316	0.00146	CcSEcCtD
Eletriptan—Asthma—Methotrexate—colon cancer	0.000315	0.00145	CcSEcCtD
Eletriptan—Flushing—Capecitabine—colon cancer	0.000315	0.00145	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000314	0.00145	CcSEcCtD
Eletriptan—ABCB1—vagina—colon cancer	0.000313	0.00529	CbGeAlD
Eletriptan—Decreased appetite—Irinotecan—colon cancer	0.000313	0.00144	CcSEcCtD
Eletriptan—Insomnia—Fluorouracil—colon cancer	0.000312	0.00144	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Irinotecan—colon cancer	0.000311	0.00143	CcSEcCtD
Eletriptan—Fatigue—Irinotecan—colon cancer	0.00031	0.00143	CcSEcCtD
Eletriptan—Paraesthesia—Fluorouracil—colon cancer	0.00031	0.00143	CcSEcCtD
Eletriptan—Pain—Irinotecan—colon cancer	0.000308	0.00142	CcSEcCtD
Eletriptan—Constipation—Irinotecan—colon cancer	0.000308	0.00142	CcSEcCtD
Eletriptan—Dyspnoea—Fluorouracil—colon cancer	0.000307	0.00142	CcSEcCtD
Eletriptan—Somnolence—Fluorouracil—colon cancer	0.000307	0.00141	CcSEcCtD
Eletriptan—Immune system disorder—Capecitabine—colon cancer	0.000306	0.00141	CcSEcCtD
Eletriptan—Chills—Capecitabine—colon cancer	0.000304	0.0014	CcSEcCtD
Eletriptan—Dyspepsia—Fluorouracil—colon cancer	0.000304	0.0014	CcSEcCtD
Eletriptan—Arrhythmia—Capecitabine—colon cancer	0.000303	0.00139	CcSEcCtD
Eletriptan—Abdominal discomfort—Methotrexate—colon cancer	0.000302	0.00139	CcSEcCtD
Eletriptan—Gastrointestinal pain—Vincristine—colon cancer	0.000302	0.00139	CcSEcCtD
Eletriptan—Decreased appetite—Fluorouracil—colon cancer	0.0003	0.00138	CcSEcCtD
Eletriptan—Alopecia—Capecitabine—colon cancer	0.0003	0.00138	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000298	0.00137	CcSEcCtD
Eletriptan—Feeling abnormal—Irinotecan—colon cancer	0.000297	0.00137	CcSEcCtD
Eletriptan—Pain—Fluorouracil—colon cancer	0.000295	0.00136	CcSEcCtD
Eletriptan—Gastrointestinal pain—Irinotecan—colon cancer	0.000294	0.00136	CcSEcCtD
Eletriptan—Abdominal pain—Vincristine—colon cancer	0.000292	0.00135	CcSEcCtD
Eletriptan—Body temperature increased—Vincristine—colon cancer	0.000292	0.00135	CcSEcCtD
Eletriptan—Flatulence—Capecitabine—colon cancer	0.000291	0.00134	CcSEcCtD
Eletriptan—Erectile dysfunction—Methotrexate—colon cancer	0.00029	0.00134	CcSEcCtD
Eletriptan—Dysgeusia—Capecitabine—colon cancer	0.000289	0.00133	CcSEcCtD
Eletriptan—Back pain—Capecitabine—colon cancer	0.000286	0.00131	CcSEcCtD
Eletriptan—Abdominal pain—Irinotecan—colon cancer	0.000285	0.00131	CcSEcCtD
Eletriptan—Body temperature increased—Irinotecan—colon cancer	0.000285	0.00131	CcSEcCtD
Eletriptan—Feeling abnormal—Fluorouracil—colon cancer	0.000284	0.00131	CcSEcCtD
Eletriptan—Muscle spasms—Capecitabine—colon cancer	0.000284	0.00131	CcSEcCtD
Eletriptan—Drowsiness—Methotrexate—colon cancer	0.000281	0.00129	CcSEcCtD
Eletriptan—Tremor—Capecitabine—colon cancer	0.000277	0.00127	CcSEcCtD
Eletriptan—Stomatitis—Methotrexate—colon cancer	0.000274	0.00126	CcSEcCtD
Eletriptan—Ill-defined disorder—Capecitabine—colon cancer	0.000274	0.00126	CcSEcCtD
Eletriptan—Urticaria—Fluorouracil—colon cancer	0.000274	0.00126	CcSEcCtD
Eletriptan—Conjunctivitis—Methotrexate—colon cancer	0.000273	0.00126	CcSEcCtD
Eletriptan—Anaemia—Capecitabine—colon cancer	0.000273	0.00126	CcSEcCtD
Eletriptan—Body temperature increased—Fluorouracil—colon cancer	0.000273	0.00125	CcSEcCtD
Eletriptan—Hypersensitivity—Vincristine—colon cancer	0.000272	0.00125	CcSEcCtD
Eletriptan—Sweating—Methotrexate—colon cancer	0.00027	0.00124	CcSEcCtD
Eletriptan—Malaise—Capecitabine—colon cancer	0.000266	0.00123	CcSEcCtD
Eletriptan—Epistaxis—Methotrexate—colon cancer	0.000265	0.00122	CcSEcCtD
Eletriptan—Vertigo—Capecitabine—colon cancer	0.000265	0.00122	CcSEcCtD
Eletriptan—Hypersensitivity—Irinotecan—colon cancer	0.000265	0.00122	CcSEcCtD
Eletriptan—Asthenia—Vincristine—colon cancer	0.000265	0.00122	CcSEcCtD
Eletriptan—Syncope—Capecitabine—colon cancer	0.000265	0.00122	CcSEcCtD
Eletriptan—Leukopenia—Capecitabine—colon cancer	0.000264	0.00122	CcSEcCtD
Eletriptan—ABCB1—liver—colon cancer	0.000264	0.00446	CbGeAlD
Eletriptan—Palpitations—Capecitabine—colon cancer	0.000261	0.0012	CcSEcCtD
Eletriptan—Loss of consciousness—Capecitabine—colon cancer	0.000259	0.00119	CcSEcCtD
Eletriptan—Asthenia—Irinotecan—colon cancer	0.000258	0.00119	CcSEcCtD
Eletriptan—Cough—Capecitabine—colon cancer	0.000258	0.00119	CcSEcCtD
Eletriptan—Hypertension—Capecitabine—colon cancer	0.000255	0.00117	CcSEcCtD
Eletriptan—Hypersensitivity—Fluorouracil—colon cancer	0.000254	0.00117	CcSEcCtD
Eletriptan—Diarrhoea—Vincristine—colon cancer	0.000253	0.00116	CcSEcCtD
Eletriptan—Arthralgia—Capecitabine—colon cancer	0.000251	0.00116	CcSEcCtD
Eletriptan—Myalgia—Capecitabine—colon cancer	0.000251	0.00116	CcSEcCtD
Eletriptan—Pharyngitis—Methotrexate—colon cancer	0.000251	0.00115	CcSEcCtD
Eletriptan—Anxiety—Capecitabine—colon cancer	0.00025	0.00115	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00025	0.00115	CcSEcCtD
Eletriptan—Urinary tract disorder—Methotrexate—colon cancer	0.000249	0.00115	CcSEcCtD
Eletriptan—Discomfort—Capecitabine—colon cancer	0.000248	0.00114	CcSEcCtD
Eletriptan—Urethral disorder—Methotrexate—colon cancer	0.000247	0.00114	CcSEcCtD
Eletriptan—Diarrhoea—Irinotecan—colon cancer	0.000246	0.00113	CcSEcCtD
Eletriptan—Dry mouth—Capecitabine—colon cancer	0.000246	0.00113	CcSEcCtD
Eletriptan—Dizziness—Vincristine—colon cancer	0.000244	0.00113	CcSEcCtD
Eletriptan—Pruritus—Fluorouracil—colon cancer	0.000244	0.00112	CcSEcCtD
Eletriptan—Visual impairment—Methotrexate—colon cancer	0.000243	0.00112	CcSEcCtD
Eletriptan—Confusional state—Capecitabine—colon cancer	0.000243	0.00112	CcSEcCtD
Eletriptan—Oedema—Capecitabine—colon cancer	0.000241	0.00111	CcSEcCtD
Eletriptan—Dizziness—Irinotecan—colon cancer	0.000238	0.0011	CcSEcCtD
Eletriptan—Shock—Capecitabine—colon cancer	0.000237	0.00109	CcSEcCtD
Eletriptan—Nervous system disorder—Capecitabine—colon cancer	0.000236	0.00109	CcSEcCtD
Eletriptan—Diarrhoea—Fluorouracil—colon cancer	0.000236	0.00109	CcSEcCtD
Eletriptan—Tinnitus—Methotrexate—colon cancer	0.000235	0.00108	CcSEcCtD
Eletriptan—Tachycardia—Capecitabine—colon cancer	0.000235	0.00108	CcSEcCtD
Eletriptan—Vomiting—Vincristine—colon cancer	0.000235	0.00108	CcSEcCtD
Eletriptan—Skin disorder—Capecitabine—colon cancer	0.000234	0.00108	CcSEcCtD
Eletriptan—Rash—Vincristine—colon cancer	0.000233	0.00107	CcSEcCtD
Eletriptan—Hyperhidrosis—Capecitabine—colon cancer	0.000233	0.00107	CcSEcCtD
Eletriptan—Dermatitis—Vincristine—colon cancer	0.000233	0.00107	CcSEcCtD
Eletriptan—Headache—Vincristine—colon cancer	0.000232	0.00107	CcSEcCtD
Eletriptan—Anorexia—Capecitabine—colon cancer	0.00023	0.00106	CcSEcCtD
Eletriptan—Vomiting—Irinotecan—colon cancer	0.000229	0.00105	CcSEcCtD
Eletriptan—Immune system disorder—Methotrexate—colon cancer	0.000228	0.00105	CcSEcCtD
Eletriptan—Dizziness—Fluorouracil—colon cancer	0.000228	0.00105	CcSEcCtD
Eletriptan—Rash—Irinotecan—colon cancer	0.000227	0.00105	CcSEcCtD
Eletriptan—Dermatitis—Irinotecan—colon cancer	0.000227	0.00104	CcSEcCtD
Eletriptan—Chills—Methotrexate—colon cancer	0.000227	0.00104	CcSEcCtD
Eletriptan—Headache—Irinotecan—colon cancer	0.000226	0.00104	CcSEcCtD
Eletriptan—Hypotension—Capecitabine—colon cancer	0.000225	0.00104	CcSEcCtD
Eletriptan—Alopecia—Methotrexate—colon cancer	0.000223	0.00103	CcSEcCtD
Eletriptan—Nausea—Vincristine—colon cancer	0.00022	0.00101	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00022	0.00101	CcSEcCtD
Eletriptan—Vomiting—Fluorouracil—colon cancer	0.000219	0.00101	CcSEcCtD
Eletriptan—Insomnia—Capecitabine—colon cancer	0.000218	0.001	CcSEcCtD
Eletriptan—Rash—Fluorouracil—colon cancer	0.000217	0.001	CcSEcCtD
Eletriptan—Dermatitis—Fluorouracil—colon cancer	0.000217	0.001	CcSEcCtD
Eletriptan—Paraesthesia—Capecitabine—colon cancer	0.000216	0.000996	CcSEcCtD
Eletriptan—Headache—Fluorouracil—colon cancer	0.000216	0.000994	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—colon cancer	0.000215	0.000991	CcSEcCtD
Eletriptan—Dyspnoea—Capecitabine—colon cancer	0.000215	0.000989	CcSEcCtD
Eletriptan—Nausea—Irinotecan—colon cancer	0.000214	0.000984	CcSEcCtD
Eletriptan—Back pain—Methotrexate—colon cancer	0.000213	0.000979	CcSEcCtD
Eletriptan—Dyspepsia—Capecitabine—colon cancer	0.000212	0.000976	CcSEcCtD
Eletriptan—Decreased appetite—Capecitabine—colon cancer	0.000209	0.000964	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Capecitabine—colon cancer	0.000208	0.000958	CcSEcCtD
Eletriptan—Fatigue—Capecitabine—colon cancer	0.000208	0.000956	CcSEcCtD
Eletriptan—Pain—Capecitabine—colon cancer	0.000206	0.000949	CcSEcCtD
Eletriptan—Constipation—Capecitabine—colon cancer	0.000206	0.000949	CcSEcCtD
Eletriptan—Nausea—Fluorouracil—colon cancer	0.000205	0.000943	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—colon cancer	0.000204	0.000939	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—colon cancer	0.000203	0.000935	CcSEcCtD
Eletriptan—ABCB1—lymph node—colon cancer	0.000203	0.00342	CbGeAlD
Eletriptan—Feeling abnormal—Capecitabine—colon cancer	0.000199	0.000914	CcSEcCtD
Eletriptan—Malaise—Methotrexate—colon cancer	0.000198	0.000912	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—colon cancer	0.000197	0.000909	CcSEcCtD
Eletriptan—Gastrointestinal pain—Capecitabine—colon cancer	0.000197	0.000907	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—colon cancer	0.000197	0.000906	CcSEcCtD
Eletriptan—Cough—Methotrexate—colon cancer	0.000192	0.000883	CcSEcCtD
Eletriptan—Urticaria—Capecitabine—colon cancer	0.000191	0.000881	CcSEcCtD
Eletriptan—Body temperature increased—Capecitabine—colon cancer	0.00019	0.000877	CcSEcCtD
Eletriptan—Abdominal pain—Capecitabine—colon cancer	0.00019	0.000877	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—colon cancer	0.00019	0.000877	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—colon cancer	0.000187	0.000861	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—colon cancer	0.000187	0.000861	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000186	0.000855	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—colon cancer	0.000185	0.000851	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—colon cancer	0.000181	0.000833	CcSEcCtD
Eletriptan—Hypersensitivity—Capecitabine—colon cancer	0.000178	0.000817	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—colon cancer	0.000176	0.00081	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—colon cancer	0.000174	0.000802	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—colon cancer	0.000173	0.000798	CcSEcCtD
Eletriptan—Asthenia—Capecitabine—colon cancer	0.000173	0.000796	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—colon cancer	0.000171	0.000787	CcSEcCtD
Eletriptan—Pruritus—Capecitabine—colon cancer	0.00017	0.000785	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—colon cancer	0.000168	0.000772	CcSEcCtD
Eletriptan—Diarrhoea—Capecitabine—colon cancer	0.000165	0.000759	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000163	0.000752	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—colon cancer	0.000162	0.000747	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—colon cancer	0.000161	0.000742	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—colon cancer	0.00016	0.000736	CcSEcCtD
Eletriptan—Somnolence—Methotrexate—colon cancer	0.000159	0.000734	CcSEcCtD
Eletriptan—Dizziness—Capecitabine—colon cancer	0.000159	0.000734	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—colon cancer	0.000158	0.000727	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—colon cancer	0.000156	0.000718	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—colon cancer	0.000155	0.000713	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—colon cancer	0.000155	0.000712	CcSEcCtD
Eletriptan—Pain—Methotrexate—colon cancer	0.000153	0.000706	CcSEcCtD
Eletriptan—Vomiting—Capecitabine—colon cancer	0.000153	0.000705	CcSEcCtD
Eletriptan—Rash—Capecitabine—colon cancer	0.000152	0.000699	CcSEcCtD
Eletriptan—Dermatitis—Capecitabine—colon cancer	0.000152	0.000699	CcSEcCtD
Eletriptan—Headache—Capecitabine—colon cancer	0.000151	0.000695	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—colon cancer	0.000148	0.00068	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—colon cancer	0.000147	0.000675	CcSEcCtD
Eletriptan—Nausea—Capecitabine—colon cancer	0.000143	0.000659	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—colon cancer	0.000142	0.000656	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—colon cancer	0.000142	0.000653	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—colon cancer	0.000142	0.000653	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—colon cancer	0.000132	0.000608	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—colon cancer	0.000129	0.000592	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—colon cancer	0.000127	0.000584	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—colon cancer	0.000123	0.000565	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—colon cancer	0.000119	0.000546	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—colon cancer	0.000114	0.000525	CcSEcCtD
Eletriptan—Rash—Methotrexate—colon cancer	0.000113	0.000521	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—colon cancer	0.000113	0.00052	CcSEcCtD
Eletriptan—Headache—Methotrexate—colon cancer	0.000112	0.000517	CcSEcCtD
Eletriptan—Nausea—Methotrexate—colon cancer	0.000107	0.000491	CcSEcCtD
